6th Global Pharma SFE Forum

Fleming Europe15 - 16 March 2011, Lisbon, Portugal.
Following the previous five successful SFE conferences, Fleming Europe announced the 6th Pharma SFE Forum. The conventional conference program has been changed to interactive simulation games, case studies discussions, panel and round table sessions. Global Pharma SFE Forum is focused solely on interaction between attendees and expert presenters.

The 2 Focused Streams (Sales, Marketing, CRM, HR, and Training) will consist of Hands-on Case Studies, Workshops, Simulation presentations and Panel discussions.

Case Studies:

  • Detect Recent Trends and Future of Commercial Model
  • Targeting Effectiveness with right Metrics
  • How to Enjoy Change? Challenge of Merger- Acquisition Process
  • Where do you Spend your Promotional Dollar?
  • Using Marketing Simulation to Drive Brand Awareness
  • Innovative Approaches for Creative Marketing and Increasing Sales Trough Diverse, Multi Channel Initiatives
  • Hiring Pharma Sales Reps: Getting the Process Right
  • The Evolving Training Needs of Pharma Sales Force
  • What they "do" they learn: Most Effective Training For Your Sales Force "Simulation Gaming"
  • Achieving a CRM project success
  • Sales Territory Analysis and Optimization
  • Overcoming Restricted Access to Physicians
  • Using Technology to achieve sales force effectiveness
  • Determining Sales Force Size
  • Motivating and Compensating the Sales Force
  • Discovering Proven Methods to Measure the Impact of your Incentives
  • Value your Sales Talents, Cultural Differences

Workshops:

  • Use the opportunity to interact with presenters face-to-face to ask your questions and brainstorm with your peers.

Keynote:

  • Brand-New Holistic Approach of Pharmaceutical Sales Model

Fleming Europe has gathered almost 20 Vice Presidents, Global Heads and Senior Directors. A special part is an evening event to discover Lisbon and enjoy its finest spring hour.

For further information and registration, please visit:
http://www.sfeforum.com

About Fleming Europe conferences
Fleming Europe conferences are events linking business with intelligence. Carefully designed to provide key strategic business information and the best networking opportunities for the participants, our B2B conferences are highly interactive. Number of delegates from specialized industry sectors - brought together by Fleming Europe - become part of a premium community discussing the questions of the day and enjoying the value of a five star event.

Most Popular Now

Top 20 breaking World Pharma News of 2017

We are proud to announce the top 20 most popular breaking World Pharma News from 2017. Have a wonderful 2018 new(s) year filled with health, happiness, and spectacular su...

Novartis advances head-to-head superiority trials …

Novartis announced today the initiation of SURPASS, a head-to-head clinical trial of Cosentyx® (secukinumab) versus proposed biosimilar adalimumab** in ankylosing spondyl...

Roche and Ignyta reach definitive merger agreement

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. (NASDAQ: RXDX) today announced they have entered into a definitive merger agreement for Roche to fully acquire Ignyta ...

Antidepressant may help combat the course of multi…

The antidepressant clomipramine may also alleviate symptoms of multiple sclerosis (MS), specifically in its progressive form, i.e. when it occurs without relapses or remi...

Diabetes drug 'significantly reverses memory loss…

A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action...

FDA updates the label of Tasigna to reflect that c…

The U.S. Food and Drug Administration today updated the product label for the cancer drug Tasigna (nilotonib) to include information for providers about how to discontinu...

Zika remains a research and public health challeng…

Since 2016, when Zika was declared by the World Health Organization as a public health emergency of international concern, the virus has become established in more than 8...

Try exercise to improve memory, thinking

For patients with mild cognitive impairment, don't be surprised if your health care provider prescribes exercise rather than medication. A new guideline for medical pract...

Sandoz regulatory submission for proposed biosimil…

Sandoz, a Novartis division and the global leader in biosimilar medicines, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics Licen...

Dirt-dwelling microbe produces potential anti-mela…

A type of soil-dwelling bacterium produces molecules that induce death in melanoma cells, research at Oregon State University shows. The molecule is a secondary metabolit...

Novartis Kisqali® received FDA Breakthrough Therap…

Novartis today announced Kisqali® (ribociclib) received US Food and Drug Administration (FDA) Breakthrough Therapy designation for initial endocrine-based treatment of pr...

FDA approves first treatment for breast cancer wit…

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast can...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]